These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16532540)

  • 1. New warning on birth control patch.
    FDA Consum; 2006; 40(1):4. PubMed ID: 16532540
    [No Abstract]   [Full Text] [Related]  

  • 2. The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns.
    Wooltorton E
    CMAJ; 2006 Jan; 174(2):164-5. PubMed ID: 16368722
    [No Abstract]   [Full Text] [Related]  

  • 3. How should we advise patients about the contraceptive patch, given the FDA warning?
    Thacker HL; Falcone T; Atreja A; Jain A; Harris CM
    Cleve Clin J Med; 2006 Jan; 73(1):45-7. PubMed ID: 16444915
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormonal contraceptive patch].
    Lidegaard O
    Ugeskr Laeger; 2004 Oct; 166(41):3591. PubMed ID: 15515462
    [No Abstract]   [Full Text] [Related]  

  • 5. Women prefer Ortho Evra patch.
    AWHONN Lifelines; 2003; 7(5):460. PubMed ID: 14628730
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transdermal contraception--a new beginning].
    Sigridov I; Dikov I; Ivanov S
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():19-27. PubMed ID: 15323313
    [No Abstract]   [Full Text] [Related]  

  • 7. New contraception options.
    Smith MJ
    Diabetes Self Manag; 2004; 21(5):20-2, 25. PubMed ID: 15586908
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal contraception: recent advances.
    Szarewski A
    J Fam Health Care; 2006; 16(2):35-6. PubMed ID: 16715750
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppression of estrogen-withdrawal headache with extended transdermal contraception.
    LaGuardia KD; Fisher AC; Bainbridge JD; LoCoco JM; Friedman AJ
    Fertil Steril; 2005 Jun; 83(6):1875-7. PubMed ID: 15950671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drugs 2003, part II.
    Hussar D
    Nursing; 2003 Jul; 33(7):57-62; quiz 63-4. PubMed ID: 12851504
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical study of transdermal contraceptive patch in Thai adolescence women.
    Piyasirisilp R; Taneepanichskul S
    J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal hormonal contraception: benefits and risks.
    Burkman RT
    Am J Obstet Gynecol; 2007 Aug; 197(2):134.e1-6. PubMed ID: 17689623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical study of transdermal contraceptive patch in Thai women.
    Suwanmalee O; Taneepanichskul S
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S1-4. PubMed ID: 17726805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evra contraceptive patch: risks of thromboembolism.
    Prescrire Int; 2007 Jun; 16(89):113-4. PubMed ID: 17590909
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
    Johnson JV; Lowell J; Badger GJ; Rosing J; Tchaikovski S; Cushman M
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):278-84. PubMed ID: 18238963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light coagulation treatment of the iatrogenic, menopausal retinal vasculopathy in women.
    Urrets-Zavalía A
    Trans Ophthalmol Soc U K (1962); 1971; 91():387-97. PubMed ID: 5291537
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of norelgestromin in rabbit plasma by LC-MS/MS and its application to the pharmacokinetic study of ORTHO EVRA.
    Liu X; Ding C; Ge Q; Zhi X; Zhou Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):311-5. PubMed ID: 19097950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
    Jick SS; Jick H
    Contraception; 2006 Oct; 74(4):290-2. PubMed ID: 16982227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of steroids Part 50. Derivatization of ketosteroids for their separation and determination by capillary electrophoresis.
    Görög S; Gazdag M; Kemenes-Bakos P
    J Pharm Biomed Anal; 1996 Jun; 14(8-10):1115-24. PubMed ID: 8818023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic contact dermatitis due to transdermal contraception patch.
    Stricker T; Sennhauser FH
    J Pediatr; 2006 Jun; 148(6):845. PubMed ID: 16769403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.